Waters, Omics LLC Partner to Advance Petroleum Sample Analysis
News Jun 16, 2014
Waters Corporation announced that Omics LLC’s PetroOrg Petroleomics Software is now available for Waters® SYNAPT® G2-Si. The combined solution delivers time saving performance, enhanced results and comprehensive data for chemical composition characterization of petroleum.
Energy companies seek better analytical methodologies to determine crude oil’s economic value and the level of refining required to produce high-value products. However, the extremely high complexity of crude oils offers a significant challenge to analytical chemists. Processing, visualizing, and interpreting the information rich mass spectral data has traditionally been a costly and time-consuming process.
Waters and Omics LLC now make it possible to effortlessly access and correlate accurate mass and ion mobility information derived from Waters’ SYNAPT HDMS® for petroleum compounds. By bringing together Waters unique ion mobility-high resolution mass spectrometry platform with PetroOrg Petroleomics Software, analytical chemists can easily and quickly classify petroleum samples by chemical composition.
“We’re thrilled to partner with Omics LLC on this innovative solution. Now, classification of chemical compounds in complex petroleum samples is available with Waters’ HDMS using ion mobility and the processing is turn-key,” said Dr. Rohit Khanna, Vice-President, Worldwide Marketing and Informatics, Waters Division.
Ryan Rodgers, Director of Future Fuels Institute and Managing Member of Omics LLC added, “The challenge in Petroleomics is to move away from the ‘one and done’ approach and to mature the field by advancing to large sample numbers that capture upstream and downstream issues. To achieve this goal, PetroOrg quickly captures, processes, and confidently assigns molecular level information from multiple analytical platforms. The software is the culmination of a decade of mass spectral expertise in the molecular-level characterization of complex petroleum fluids.”
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
The architecture of each person’s brain is unique, and differences may influence how quickly people can complete various cognitive tasks.o learn more, scientists are developing a new tool — computational models of the brain — to simulate how the structure of the brain may impact brain activity and, ultimately, human behavior.READ MORE
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019